|
The ABL Advisor Deal Tables
SELECTED TRANSACTION DETAILS
Oxford Finance Provides Up to $150MM Term Loan to Inhibrx Biosciences
Tuesday, January 14, 2025
|
Lenders/Participants
|
Oxford Finance [Lender]
|
|
Structure
|
Term Loan
|
|
Amount
|
$150.000
Million
|
|
Borrower(s)
|
Inhibrx Biosciences
|
|
Description
|
A five-year term loan facility for up to $150 million. The Credit Facility closed on January 13, 2025. Pursuant to the LSA, the Company received an initial Term Loan of $100 million funded on the Closing Date. An additional $50 million may be made available at the Company's request and subject to the Lenders' discretion. The repayment schedule provides for interest-only payments until March 2028. As part of the agreement, Inhibrx also issued to the Lenders warrants to purchase an aggregate of 140,741 shares of Inhibrx's common stock, which is equal to 2% of the value of the initial term loan divided by a strike price of $14.21 per share. Additional warrants will become issuable in connection with any additional funding by the Lenders.
|
|
Industry
|
Biopharmaceuticals
|
|
Location
|
CA
|
| Related Tags |
Biopharmaceuticals, Non-bank Lender, Oxford Finance
|
ABL Advisor
Deal Tables
2025
|
|
|
|